Cibc Private Wealth Group, LLC Guardant Health, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 244 shares of GH stock, worth $11,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244
Previous 244
-0.0%
Holding current value
$11,248
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
348Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$518 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$296 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$251 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$241 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.71B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...